Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL541064 | 0.82 | ALDH1A1 (0.45) | ALDH1A1TSHRTHRB | |
| SCHEMBL788324 | 0.80 | ALDH1A1 (0.43) | ALDH1A1TSHRTHRB | |
| Acetic Acid SCHEMBL28822470 | 0.68 | ALDH1A1 (0.58) | ALDH1A1TSHRTHRB | |
| SCHEMBL21835936 | 0.68 | — | — | |
| Acetic Acid SCHEMBL27325136 | 0.68 | ALDH1A1 (0.58) | ALDH1A1TSHRTHRB | |
| SCHEMBL23165292 | 0.68 | CYP1A2 (0.36) | ALDH1A1THRB | |
| SCHEMBL15532281 | 0.68 | — | — | |
| SCHEMBL14926861 | 0.67 | ALDH1A1 (0.58) | ALDH1A1TSHRTHRB | |
| SCHEMBL29219066 | 0.67 | ALDH1A1 (0.42) | ALDH1A1TSHRTHRB | |
| SCHEMBL5932911 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10507262-B2 | Biocompatible hydrogel treatments for retinal detachment | C.P. MEDICAL CORPORATION (US) | 2019-12-17 | — | — | US | disclosed |
| US-20180036452-A1 | BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT | MEDICUS BIOSCIENCES LLC | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180036452-A1 | BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT | ALDH1A2, RB1, UACA | ALDH1A1 297/4885TSHR 1883/4885THRB 1990/4885 |
| US-10507262-B2 | Biocompatible hydrogel treatments for retinal detachment | ALDH1A2, RB1, UACA | ALDH1A1 297/4885TSHR 1883/4885THRB 1990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.